channelnewsasia.com - S'pore institute creates world's first contact lens that darkens in sunlight
   
 
  blogs  
 
yournews
   
   
 
Video Finance Lifestyle Travel Weather Discussion TV Shows
CNA Live    | About Us 
 
  Home ›
 
Singapore News

 
 

S'pore institute creates world's first contact lens that darkens in sunlight
By Wang Eng Eng, Channel NewsAsia | Posted: 03 November 2009 1609 hrs

 
 
Photos  of

   
 

SINGAPORE: The world's first "photochromic" contact lens that darkens under sunlight has been created by Singapore's Institute of Bioengineering and Nanotechnology (IBN).

IBN is now negotiating a licensing agreement with two companies to make and sell the lenses for markets overseas.

Senior Minister of State for Trade and Industry S Iswaran opened IBN iCare, its new S$5 million lab at the Biopolis on Tuesday. He said the market potential is promising, with 310 million people worldwide who need their vision corrected.

The contact lens market size is estimated at US$6 billion and growing at five to 10 per cent each year.

It may look like any other ordinary lens, but the "photochromic" contact lens is able to change colour to protect your eyes against harmful ultraviolet radiation and glare. The lead researcher said the dyes within the nano structure of the lens are able to respond faster to light changes.

Dr Edwin Chow, team leader & senior research scientist, Institute of Bioengineering & Nanotechnology, said: "It enables a faster response time which means the time to change colour back and fade back to its original colour happens within seconds. This is amazing compared to the normal transition glasses which takes a few minutes for it to change back to colour."

It took less than a year to develop and it is expected to become commercially available within a year.

The lab is focusing on developing applications to treat eye diseases such as glaucoma through the use of drug loaded contact lens.

IBN iCare is Funded by Exploit Technologies, the commercialization arm of the Agency for Science, Technology and Research, or A*STAR. It will collaborate with NUH Eye Centre to conduct clinical trials prior to commercialization.

Boon Swan Foo, executive chairman, Exploit Technologies, A*STAR, said: "Anything that is done by the research lab has to be applied. In this case, the clinicians in NUH were extremely excited and enthused by the material developed by Edwin at IBN. Because of that, they want to try them under clinical settings."

In addition to providing eye-care services such as lasik and refractive surgery for patients, NUH Eye Centre will also offer innovative treatments of vision correction using IBN's biomaterials. - CNA/vm

 

 
Add Your Comments   View Comments ()
Name : E-mail:
Your views   (Max 600 chars)
word count:   more chars available.
........................................................................................................................................
Enter the code exactly as you see it.
I have read terms & conditions
  



Other singapore News
Ren Ci founder sentenced to 10 months' jail
First batch of 50 electric vehicles to arrive next year
Concerns over demand & supply of HDB flats to be raised in Parliament
CASE, NTUC Income sued by 2 private schools for some S$10m
SM Goh urges board members of charities to provide better leadership
Thursday's floods an event that occurs once every 50 years
4 under investigation for selling illegal medicines over Internet
Singapore's F-15 fighter jets inaugurated in US by DPM Teo
10 people arrested for loansharking activities
Panel on Clean Energy identifies key areas of focus for S'pore
New exhibition of photos taken by HIV & AIDS sufferers
SGX Bull Charge charity run raises over S$2m for 12 beneficiaries
Foreign Minister Yeo addresses 3,000 Chinese entrepreneurs in Manila
Design festival, award exhibition launched at ION Orchard
Prime Taxis to roll out 30 hybrid cabs on Saturday

 

 
Affiliate Sites:
 
About Us  |  Contact Us  |  Advertise with Us  |  Terms & Conditions